<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dk.um.si/IzpisGradiva.php?id=72580"><dc:title>Combating counterfeiting of medicines in the Republic of Belarus</dc:title><dc:creator>Saschenko,	Pavel	(Avtor)
	</dc:creator><dc:creator>,	Univerza v Mariboru	(Lastnik avtorskih pravic)
	</dc:creator><dc:subject>medicine</dc:subject><dc:subject>counterfeiting of medicines</dc:subject><dc:subject>crime</dc:subject><dc:subject>criminal liability</dc:subject><dc:subject>administrative liability</dc:subject><dc:subject>Belarus</dc:subject><dc:description>Counterfeiting of medicines constitutes as a threat to public health, which nowadays has a “pandemic character”. In this regard, the legislation of the Republic of Belarus should properly address the risks caused by counterfeited medicines. Being a member of several economic alliances aimed at simplifying turnover of goods, including medical products, Belarus needs to develop comprehensive preventive measures and provide effective and proportionate criminal and other sanctions for the commission of acts connected with counterfeiting of medicines. This article focuses on key factors which impact the development of Belorussian legislation. The main obstacles for effective international cooperation in criminal matters concerning turnover of counterfeit medicines are also explored. Amendments to legislation aimed at improving the effectiveness of combating counterfeiting of medicines will also be discussed.</dc:description><dc:date>2017</dc:date><dc:date>2018-10-09 10:01:06</dc:date><dc:type>Znanstveno delo</dc:type><dc:identifier>72580</dc:identifier><dc:language>sl</dc:language><dc:rights>Univerza v Mariboru</dc:rights></rdf:Description></rdf:RDF>
